Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C
about
Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver diseaseMetabolic factors and chronic hepatitis C: a complex interplayEligibility of persons who inject drugs for treatment of hepatitis C virus infection.The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.Processes to manage analyses and publications in a phase III multicenter randomized clinical trialInsulin resistance and chronic liver disease.I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis.Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.Coffee and Liver DiseaseCoffee and liver - long way to go.Treatment of patients with genotype 3 chronic hepatitis C--current and future therapies.New therapeutic paradigm for patients with cirrhosis.Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.Impact of coffee on liver diseases: a systematic review.Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.Coffee intake linked to improved SVR in patients undergoing treatment for hepatitis C.Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).Caffeine is protective in patients with non-alcoholic fatty liver disease.Clinical trials and their translation in hepatology: past, present, and future.
P2860
Q26784396-2E9D93B0-A1B7-4BBC-B60E-B111CCA0516AQ27011787-D0852233-4E34-47CD-B6FA-3B18AB55F3A5Q30429470-3F84FCCA-0E2D-42A2-98B0-C46DACD6AF3DQ31022208-C77D464A-95F0-474E-A268-33604300F448Q33694159-174237C5-B786-4C70-88FE-BFE47822E2D1Q35073012-2F9C32B7-746B-4D4B-9276-08AE110CA5FAQ35560040-9C393C19-9931-4C91-9EE1-A8AB38EC7CE9Q36188710-E8547289-4492-4DFC-971F-2BA21FDDDE60Q36886788-F3FA76A9-D646-4C6D-B8B1-8305E40F5BA1Q37613528-04BA5B98-0FF7-41CB-ACC8-0FA03431DFB9Q37972774-0652EDED-4784-4BF8-B13F-30E7E19595CCQ38021413-49B2AF1F-DE55-4086-B71A-2CA6D5F628E0Q38136078-B353F7F2-BCE7-425C-B70D-98AC16FBCA08Q38150457-20E522C9-6149-48B3-AB6D-5F7EC92ADAACQ38160516-30E0013F-0A96-4B51-B245-3A45A1FB7AFAQ38192047-82ECB4D4-185F-4EB3-A8A5-06DCCFB56A31Q38354450-A60D8FA7-6116-46EA-A025-11BD2FE5C5EDQ40376800-2D8C9D28-0BD1-4276-A11D-30BCB872FF7CQ41207222-ADED7A75-878C-4956-9C07-F912E099F925Q46818665-62994876-0F2F-4E33-8B15-AF77E53A9598Q51643325-39F34619-9118-4ADF-BCE6-D094292ACBDA
P2860
Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Coffee consumption is associat ...... ients with chronic hepatitis C
@ast
Coffee consumption is associat ...... ients with chronic hepatitis C
@en
type
label
Coffee consumption is associat ...... ients with chronic hepatitis C
@ast
Coffee consumption is associat ...... ients with chronic hepatitis C
@en
prefLabel
Coffee consumption is associat ...... ients with chronic hepatitis C
@ast
Coffee consumption is associat ...... ients with chronic hepatitis C
@en
P2093
P2860
P1433
P1476
Coffee consumption is associat ...... ients with chronic hepatitis C
@en
P2093
Elizabeth C Wright
HALT-C TRIAL GROUP
James E Everhart
Karen L Lindsay
Neal D Freedman
Rashmi Sinha
Teresa M Curto
P2860
P304
P356
10.1053/J.GASTRO.2011.02.061
P407
P577
2011-03-02T00:00:00Z